Posted on March 7th, 2012 by Health News
Astex Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to partner Eisai for their supplemental New Drug Application (sNDA) for Dacogen (decitabine) for Injection for patients with acute myeloid leukemia (AML) in adults 65 years of age or older who are not considered candidates for induction [...]
No Comments »
Filed under: Pharmacy News
Posted on February 28th, 2012 by Health News
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib.
No Comments »
Filed under: Pharmacy News
Posted on February 23rd, 2012 by Health News
The U.S. Food and Drug Administration and several pharmaceutical companies said Tuesday they have reached agreements to alleviate shortages for the drugs methotrexate and Doxil. Methotrexate is used to treat children with a form of leukemia and others with tumors of the breast and lungs. Doxil is used to treat ovarian cancer and multiple myeloma.
No Comments »
Filed under: Pharmacy News
Posted on February 16th, 2012 by Health News
As the world’s largest professional society concerned with the causes and treatment of blood disorders, many of ASH’s more than 16,000 members are on the front lines of dealing with the country’s severe shortage of methotrexate, a drug critical in the treatment of children with acute lymphocytic leukemia.
No Comments »
Filed under: Pharmacy News
Posted on February 14th, 2012 by Health News
A medicine to treat children’s leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer’s disease are clamoring to use a skin-cancer drug after a promising study in mice.
No Comments »
Filed under: Pharmacy News
Posted on February 13th, 2012 by Health News
Methotrexate, a drug used to treat acute lymphoblastic leukemia, the most common childhood leukemia, is now also in short supply in the USA, along with several other lifesaving drugs. According to the FDA, vital lifesaving hospital drugs have not been so scarce in ten years. Methotrexate works by slowing down the rate at which cancer [...]
No Comments »
Filed under: Pharmacy News
Posted on February 10th, 2012 by Health News
WASHINGTON (MedPage Today) — An FDA advisory committee voted 10-3, with one abstention, against expanding the indication for decitabine (Dacogen) for use in elderly acute myelogenous leukemia (AML) patients.
No Comments »
Filed under: General Health News
Posted on February 9th, 2012 by Health News
WASHINGTON (MedPage Today) — Decitabine (Dacogen), a hypomethylating agent, does not appear to improve mortality in older patients with acute myelogenous leukemia, FDA reviewers concluded.
No Comments »
Filed under: General Health News
Posted on February 4th, 2012 by Health News
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has acquired the exclusive worldwide development and commercialization rights to ASPAREC for the treatment of acute lymphoblastic leukemia (ALL) from Alizé Pharma.
No Comments »
Filed under: Pharmacy News
Posted on January 12th, 2012 by Health News
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.
No Comments »
Filed under: Pharmacy News
